EpiMonitor is an AI-enabled medical device from Empatica Srl that the U.S. FDA cleared through 510(k) K232915 on February 15, 2024. Its lead review panel is Neurology and its primary product code is POS (Physiological Signal Based Seizure Monitoring System).
See also FDA-cleared AI neurology devices in 2024, all FDA AI clearances in 2024, top neurology AI devices.
Key facts
| Submission number | K232915 |
|---|---|
| Pathway | 510(k) |
| Date of final decision | |
| Company (FDA list) | Empatica Srl |
| Lead review panel | Neurology |
| Primary product code | POS — Physiological Signal Based Seizure Monitoring System |
| Applicant (openFDA) | Empatica S.r.l. |
| Applicant location | Milan, IT |
| Device class | Class 2 |
| Regulation number | 21 CFR 882.1580 |
| Decision code | SESE |
| Submission type | Traditional |
Source: FDA AI-Enabled Medical Devices list and openFDA.
What this means
A 510(k) is a premarket submission showing the device is substantially equivalent to a legally marketed predicate device. A cleared 510(k) means FDA agreed with that equivalence. EpiMonitor went through this pathway (K232915).
openFDA lists it as a Class 2 device under 21 CFR 882.1580. Class II devices are moderate risk and are subject to general and special controls.
Product code POS covers 4 devices on the FDA AI list. By decision date, this device is #2 of 4 under that code. Empatica Srl has 4 AI-enabled devices on the list, and the Neurology panel accounts for 73 in total.
Being on this list doesn't describe how well the device works clinically. Check the FDA record for its indications for use.
Similar devices (product code POS)
- Nelli (Version 7.11)Neuro Event Labs OY · Neurology
- EpiMonitorEmpatica Srl · Neurology
- EmbraceEmpatica Srl · Neurology